ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AZN Astrazeneca Plc

12,096.00
-14.00 (-0.12%)
20 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -14.00 -0.12% 12,096.00 12,086.00 12,092.00 12,118.00 12,038.00 12,090.00 1,525,268 16:35:02
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.47 187.42B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,110p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,432.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £187.42 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.47.

Astrazeneca Share Discussion Threads

Showing 3551 to 3574 of 6150 messages
Chat Pages: Latest  150  149  148  147  146  145  144  143  142  141  140  139  Older
DateSubjectAuthorDiscuss
22/12/2020
14:58
You know very well it has mh with the lower effectiveness regime but still better than the flu vaccine and prevented 100% of serious cases with zero hospitalisations which is excellent. Some died in the Pfizer trials after receiving the vaccine.
bountyhunter
22/12/2020
13:35
Pfizer Inc and Moderna Inc are testing their COVID-19 vaccines against the new fast-spreading version of the virus that has emerged in Britain.

Moderna expects immunity from its vaccine to protect against the variants and is performing more tests in the coming weeks to confirm, the company said.

philanderer
22/12/2020
10:41
Has it been tested on the over fifty five year olds ?
montyhedge
22/12/2020
10:13
6700p my target for Astra.
montyhedge
22/12/2020
08:47
We need all three but the Astra vaccine will be the vaccine of choice given it's 5 times cheaper and on top of that logistically far easier and cheaper to distribute and store. Not many GPs have a deep freeze let alone at -80°C!
bountyhunter
22/12/2020
08:38
UK probably will have to go for Moderna

or

Maybe Sputnik 5 if AZN recommend it perhaps

UK does need a shot in the arm at the moment and no time to dwell/wait

buywell3
21/12/2020
20:49
UK has vaccinated 500,000 people against Covid since December 8, Boris Johnson says as regulators face growing pressure to approve Oxford's jab in desperate race to speed up the roll-out
By Sam Blanchard Senior Health Reporter For Mailonline
13:30 21 Dec 2020, updated 18:17 21 Dec 2020

bountyhunter
21/12/2020
19:26
Looks all set for a rise to me based on the long term chart. That will probably follow on from a big improvement in sentiment on approval of the Oxford vaccine likely early next week. With the Astra Oxford vaccine cheap and as easy to distribute as the flu vaccine Astra is set to become the most famous pharma in the world.
bountyhunter
21/12/2020
16:52
Added acouple of lots today, would,d hope for a sentiment turn here.

Someone recently referenced £73 from a TA perspective.

essentialinvestor
21/12/2020
16:10
AZ7442 :-)
gregb
21/12/2020
14:13
Yes, but only during the pandemic.
Profits to follow whenever the pandemic is declared over and in the meantime AstraZeneca's global reputation will fly with the best global publicity possible. This vaccine or follow ups of it could be required for years to come as with the flu vaccine.
Even excluding vaccine considerations longer term (which are clearly not at this stage priced in) Astra has an enviable pipeline.
Re the vaccine a lot will depend on the details of the MHRA approval anticipated on 28 or 29 of December (see above).

bountyhunter
21/12/2020
14:04
Non profit making for Astra, so good on them.
montyhedge
21/12/2020
14:01
Vaccine costs (excluding widely varying distribution costs), EU is paying:

Oxford/AstraZeneca: €1.78 (£1.61).
Johnson & Johnson: $8.50 (£6.30).
Sanofi/GSK: €7.56.
Pfizer/BioNTech: €12.
CureVac: €10.
Moderna: $18.

bountyhunter
21/12/2020
14:00
Oxford coronavirus vaccine approval expected shortly after Christmas,government sources claim

A vaccine a developed by the University of Oxford is set to be approved within days of Christmas, according to senior Whitehall sources.

The Medicines and Healthcare Regulatory Agency (MHRA) is believed to be set to authorise the vaccines on December 28 or 29 after final data is provided to the regulator on Monday...

www.independent.co.uk/news/uk/oxford-vaccine-approve-christmas-covid-b1776481.html

bountyhunter
21/12/2020
13:59
The FDA has it's own agenda, nothing to do with clinical trials, they stopped the Astra Oxford trial in the US just to ensure that Pfizer and Moderna got to the finish line with their expesive logistically problematic vaccines first.
bountyhunter
21/12/2020
11:14
U.K. will pass, desperate, FDA will want more data, which is the right thing today.
montyhedge
21/12/2020
10:02
On that basis why carry out clinical trials at all?
alphorn
21/12/2020
09:57
Who cares about the FDA with this, so long as it's approved by the MHRA the rest of the world will soon follow regardless of the FDA who have US corporate profits in mind.
bountyhunter
21/12/2020
00:29
Hi Phil, would hope for some relative outperformance by more defensive
stocks on Monday.

essentialinvestor
21/12/2020
00:17
I reckon a lot of shares will get hammered in the morning.
philanderer
20/12/2020
21:24
I can see the Astra vaccine selling well at these prices!
bogman1
20/12/2020
20:40
If you believe the leaking of these vaccine prices was an accident, I’ve got a bridge to sell you.
donald t
20/12/2020
19:42
EU is paying:

Oxford/AstraZeneca: €1.78 (£1.61).
Johnson & Johnson: $8.50 (£6.30).
Sanofi/GSK: €7.56.
Pfizer/BioNTech: €12.
CureVac: €10.
Moderna: $18.

bountyhunter
20/12/2020
18:02
Buywell what are this weeks winning lottery numbers, you seem to know so much just wondered if you could make me rich by xmas
deadly nightshade
Chat Pages: Latest  150  149  148  147  146  145  144  143  142  141  140  139  Older

Your Recent History

Delayed Upgrade Clock